(Q34431189)

English

Evidence that cyclic AMP phosphodiesterase inhibitors suppress interleukin-2 release from murine splenocytes by interacting with a 'low-affinity' phosphodiesterase 4 conformer

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

2 August 2017

Evidence that cyclic AMP phosphodiesterase inhibitors suppress interleukin-2 release from murine splenocytes by interacting with a 'low-affinity' phosphodiesterase 4 conformer (English)

1 reference

Europe PubMed Central

2 August 2017

author name string

Souness JE

1

1 reference

Europe PubMed Central

2 August 2017

Houghton C

2

1 reference

Europe PubMed Central

2 August 2017

Sardar N

3

1 reference

Europe PubMed Central

2 August 2017

Withnall MT

4

1 reference

Europe PubMed Central

2 August 2017

language of work or name

0 references

publication date

1 June 1997

1 reference

Europe PubMed Central

2 August 2017

British Journal of Pharmacology

1 reference

Europe PubMed Central

2 August 2017

121

1 reference

Europe PubMed Central

2 August 2017

743-750

1 reference

Europe PubMed Central

2 August 2017

4

1 reference

Europe PubMed Central

2 August 2017

Identification of cyclic AMP phosphodiesterases 3, 4 and 7 in human CD4+ and CD8+ T-lymphocytes: role in regulating proliferation and the biosynthesis of interleukin-2

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701200

21 January 2018

The human cyclic AMP-specific phosphodiesterase PDE-46 (HSPDE4A4B) expressed in transfected COS7 cells occurs as both particulate and cytosolic species that exhibit distinct kinetics of inhibition by the antidepressant rolipram

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701200

21 January 2018

Phosphodiesterase 4 in macrophages: relationship between cAMP accumulation, suppression of cAMP hydrolysis and inhibition of [3H]R-(-)-rolipram binding by selective inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701200

21 January 2018

Evidence that cyclic AMP phosphodiesterase inhibitors suppress TNF alpha generation from human monocytes by interacting with a 'low-affinity' phosphodiesterase 4 conformer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701200

21 January 2018

Suppression of eosinophil function by RP 73401, a potent and selective inhibitor of cyclic AMP-specific phosphodiesterase: comparison with rolipram

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701200

21 January 2018

Stereospecificity of rolipram actions on eosinophil cyclic AMP-specific phosphodiesterase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701200

21 January 2018

Cyclic AMP counteracts mitogen-induced inositol phosphate generation and increases in intracellular Ca2+ concentrations in human lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701200

21 January 2018

Selective Type IV Phosphodiesterase Inhibitors as Antiasthmatic Agents. The Syntheses and Biological Activities of 3-(Cyclopentyloxy)-4-methoxybenzamides and Analogs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701200

7 January 2021

based on heuristic

inferred from DOI database lookup

Control of human T-lymphocyte interleukin-2 production by a cAMP-dependent pathway

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701200

7 January 2021

based on heuristic

inferred from DOI database lookup

Association of the anti-inflammatory activity of phosphodiesterase 4 (PDE4) inhibitors with either inhibition of PDE4 catalytic activity or competition for [3H]rolipram binding

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701200

7 January 2021

based on heuristic

inferred from DOI database lookup

Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701200

7 January 2021

based on heuristic

inferred from DOI database lookup

Molecular biology of the cyclic AMP-specific cyclic nucleotide phosphodiesterases: a diverse family of regulatory enzymes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701200

7 January 2021

based on heuristic

inferred from DOI database lookup

Biarylcarboxylic acids and -amides: inhibition of phosphodiesterase type IV versus [3H]rolipram binding activity and their relationship to emetic behavior in the ferret

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701200

7 January 2021

based on heuristic

inferred from DOI database lookup

High-affinity binding of staphylococcal enterotoxins A and B to HLA-DR

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701200

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of autoimmune demyelination in non-human primates by a cAMP-specific phosphodiesterase inhibitor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701200

7 January 2021

based on heuristic

inferred from DOI database lookup

IL-15, a novel T cell growth factor that shares activities and receptor components with IL-2.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701200

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of rolipram and CI-930 on IL-2 mRNA transcription in human Jurkat cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701200

7 January 2021

based on heuristic

inferred from DOI database lookup

Characterization of cAMP-dependent inhibition of LPS-induced TNF alpha production by rolipram, a specific phosphodiesterase IV (PDE IV) inhibitor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701200

7 January 2021

based on heuristic

inferred from DOI database lookup

Multiple high-affinity cAMP-phosphodiesterases in human T-lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701200

7 January 2021

based on heuristic

inferred from DOI database lookup

The specific type III and IV phosphodiesterase inhibitor zardaverine suppresses formation of tumor necrosis factor by macrophages

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701200

7 January 2021

based on heuristic

inferred from DOI database lookup

Close correlation between behavioural response and binding in vivo for inhibitors of the rolipram-sensitive phosphodiesterase.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701200

7 January 2021

based on heuristic

inferred from DOI database lookup

Stereospecific binding of the antidepressant rolipram to brain protein structures

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701200

7 January 2021

based on heuristic

inferred from DOI database lookup

Anti-inflammatory activity of phosphodiesterase (PDE)-IV inhibitors in acute and chronic models of inflammation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701200

7 January 2021

based on heuristic

inferred from DOI database lookup

The specific type IV phosphodiesterase inhibitor rolipram suppresses tumor necrosis factor-alpha production by human mononuclear cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701200

7 January 2021

based on heuristic

inferred from DOI database lookup

The antidepressant rolipram suppresses cytokine production and prevents autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701200

7 January 2021

based on heuristic

inferred from DOI database lookup

Characterization of guinea-pig eosinophil phosphodiesterase activity. Assessment of its involvement in regulating superoxide generation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701200

7 January 2021

based on heuristic

inferred from DOI database lookup

Interleukin 2 and its receptors: recent advances and new immunological functions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701200

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.BJP.0701200

1 reference

Europe PubMed Central

2 August 2017

1 reference

Europe PubMed Central

2 August 2017

1 reference

Europe PubMed Central

2 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34431189&oldid=1550501213"